CD19 and myositis disease: Following CD19 CAR T cell infusion, the patient exhibited dramatic improvement in muscle strength and endurance, reductions in creatinine kinase levels and anti-Jo-1 antibodies, and complete resolution of myositis-related lesions on MRI.